Invokana Lawsuits Centralized in New Jersey MDL

Fifty-five lawsuits against Janssen Pharmaceuticals and its type 2 diabetes drug Invokana have been transferred and centralized before New Jersey District Court Judge Brian Martinotti. The cases, all similarly alleging that the drugmaker failed to adequately warn patients about the potential risks of kidney failure, diabetic ketoacidosis and heart attacks associated with Invokana, were corralled under one umbrella for purposes of discovery and pre-trial proceedings in a mechanism known as a multi-district litigation, or MDL. So far, only cases involving Invokana and its sister medication Invokamet have been included in the MDL, excluding similar brand-name drugs.

If you or a loved one experienced complications such as kidney failure or ketoacidosis after taking Invokana, please call 888-984-7988 for a confidential evaluation of your potential claim.

Real Time Analytics